| Completed | 4 | 92 | Europe | pioglitazone, placebo | IKFE Institute for Clinical Research and Development, Takeda, Johannes Gutenberg University Mainz, Heidelberg University | Type 2 Diabetes Mellitus, Cardiovascular Disease | | 11/06 | | |
NCT01588470: Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) |
|
|
| Completed | 4 | 130 | NA | pioglitazone, Actos | The University of Texas Health Science Center at San Antonio, Takeda Pharmaceuticals North America, Inc. | Type 2 Diabetes, Coronary Heart Disease | 12/11 | 12/11 | | |